Authors: Schrama, D Straten, PT Fischer, WH McLellan, AD Brocker, EB Reisfeld, RA Becker, JC

Citation: D. Schrama et al., Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue, IMMUNITY, 14(2), 2001, pp. 111-121

Authors: Straten, PT Guldberg, P Schrama, D Andersen, MH Moerch, U Seremet, T Siedel, C Reisfeld, RA Becker, JC

Citation: Pt. Straten et al., In situ cytokine therapy: redistribution of clonally expanded T cells, EUR J IMMUN, 31(1), 2001, pp. 250-258

Authors: Schrama, D Andersen, MH Terheyden, P Schroder, L Pedersen, LO Straten, PT Becker, JC

Citation: D. Schrama et al., Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients, CANCER RES, 61(2), 2001, pp. 493-496

Authors: Moerch, U Schrama, D Guldberg, P Seremet, T Zeuthen, J Becker, JC Straten, PT

Citation: U. Moerch et al., Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma, CANCER IMMU, 49(8), 2000, pp. 426-432

Authors: Becker, JC Vetter, CS Schrama, D Brocker, EB Straten, PT

Citation: Jc. Becker et al., Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node, EUR J IMMUN, 30(12), 2000, pp. 3699-3706